ScreenerHero

ENVBEnveric Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · enveric.com
1.430USD+9.16%Mkt Cap: 6.40M $P/E: —

Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap6.40M $
Enterprise Value-2.07M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.77M $
Revenue/Share—
Last Price1.430 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS29405E2081
Valuation
P/E (Trailing)—
P/E (Forward)-0.99
PEG—
EV/EBITDA0.24
EV/Revenue—
P/S—
P/B0.35
EPS (TTM)-13.02
EPS (Forward)-1.41
52W Range
1.2501% of range17.64
52W High17.64 USD
52W Low1.250 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-209.98%
ROA-172.14%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.14M $
CapEx (TTM)—
FCF Margin—
FCF Yield-78.37%
Net Debt-8.30M $
Net Debt/EBITDA0.97
Balance Sheet
Debt/Equity—
Current Ratio10.21
Quick Ratio9.63
Book Value/Sh3.935 USD
Cash/Share1.854 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 23, 2008
Pay DateNov 25, 2019
Splits
Last Split1:12
Split DateOct 28, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.48M
Float4.31M
Insiders8.89%
Institutions12.58%
Short Interest
Short Ratio0.2d
Short % Float0.48%
Short % Out.0.47%
Shares Short19.11K
Short (prev mo.)15.68K
Technical
SMA 501.425 (+0.4%)
SMA 2002.994 (-52.2%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)114.31K
Avg Vol (10d)131.16K
Technical Indicators
RSI (14)46.1
MACD-0.0089
MACD Signal0.0005
MACD Hist.-0.0094
BB Upper1.727 USD
BB Middle1.479 USD
BB Lower1.232 USD
BB Width33.49%
ATR (14)0.1274 USD
Vol Ratio (20d)0.75x